comparemela.com

Latest Breaking News On - Phillip hains - Page 1 : comparemela.com

Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer

MELBOURNE, Australia and SAN FRANCISCO, Dec. 21, 2023 Alterity Therapeutics , a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today.

Arovella Therapeutics appoints new CFO

Arovella Therapeutics Ltd (ASX:ALA), a leading biotechnology firm specialising in invariant Natural Killer T (iNKT) cell therapy, has announced the.

Alterity Therapeutics : Voting ahead of attending the Meeting - Form 6-K -November 30, 2023 at 06:06 am EST

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.